Table 5.
Multivariate linear regression model for SBP change.
| Variable | Beta | 95% CI | p-Value |
|---|---|---|---|
| Age (years) | 0.07 | −0.28, 0.42 | 0.695 |
| Sex: male vs. female | 3.2 | −4.0, 10 | 0.38 |
| Baseline HbA1c (%) | −0.70 | −3.3, 1.9 | 0.59 |
| Baseline BMI (kg/m2) | −0.63 | −1.6, 0.30 | 0.18 |
| T2DM duration | 0.38 | 0.04, 0.72 | 0.03 |
| Dose of oral semaglutide (mg) | 0.17 | −0.79, 1.1 | 0.72 |
| Last follow-up (months) | 0.54 | −0.81, 1.9 | 0.43 |
| Monotherapy vs. association | 23 | 5.5, 40 | 0.01 |
| SWITCH vs. ADD-ON group | 5.8 | −2.5, 14 | 0.17 |
| Insulin (yes vs. no) | −0.78 | −9.8, 8.2 | 0.86 |
| SGLT2 (yes vs. no) | 1.4 | −6.0, 8.8 | 0.71 |
| R2 = 0.268; AIC = 680 |